Suppr超能文献

骨肉瘤的DNA细胞计量术

DNA cytometry of osteosarcoma.

作者信息

Bauer H C

机构信息

Department of Orthopedics, Karolinska Hospital, Stockholm, Sweden.

出版信息

Acta Orthop Scand Suppl. 1988;228:1-39. doi: 10.3109/17453678809154175.

Abstract

The relationship between cytochemical features and histomorphology in osteosarcoma, and the clinical significance of DNA content were investigated by microspectrophotometry (MSP) of tissue sections and flow cytophotometry (FCM) of cell suspensions. MSP of tissue sections entails the methodological error of determining the DNA content of sectioned cell nuclei. By analyzing 184 normal mesenchymal cell populations, an upper limit of diploidy (normal DNA content) was deduced. Applying this upper limit for 42 sarcomas, 6 were diploid and 36 hyperploid. Comparative analysis of the same lesions by MSP of imprint preparations and by FCM disclosed complete agreement in ploidy classification (diploid versus hyperploid). Retrospective MSP analysis of bone tumors is often impeded by previous demineralization in acid, which destroys DNA. EDTA as an alternative was found to slightly reduce Feulgen DNA stainability of osteosarcomas, but did not affect tumor ploidy determination. Hence, EDTA offers a means of retaining DNA stainability of bone tumors requiring demineralization. MSP analysis of different histologic areas, and comparative FCM analysis of biopsy and surgical specimens, dislosed that individual osteosarcomas are cytochemically uniform despite morphologic heterogeneity. Hence, a single tumor sample for DNA analysis can be relied upon as representative for the tumor as a whole. In a consecutive series of 83 osteosarcoma patients treated by surgery and adjuvant Interferon, the 7-year survival rate was 0.44. MSP DNA analysis gave no significant prognostic information. Multivariate analysis identified 3 risk factors for tumor related death, i.e., male sex, proximal tumor location, and histologic grade IV. In a prognostication model, the 7-year survival rates, for patients with 0, 1, 2, or 3 risk factors, were 0.80, 0.59, 0.42, and 0.13, respectively. Hence, it is possible to identify subgroups of high grade osteosarcoma patients with different prognosis. In a study of 166 primary bone tumors, the applicability of DNA analysis for differential diagnostic purposes was investigated. The series included high grade osteosarcomas, parosteal osteosarcomas and benign bone tumors, which may be mixed up histologically with osteosarcoma. Out of 166 tumors, 149 (90%) were histologically noncontroversial, whereas 17 (10%) posed diagnostic difficulties. In the diagnostically noncontroversial group, all benign tumors and parosteal osteosarcomas were diploid, whereas 97 of 102 osteosarcomas were hyperploid. Hence, hyperploidy seems to be a characteristic feature of high grade osteosarcoma.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

通过组织切片的显微分光光度法(MSP)和细胞悬液的流式细胞光度法(FCM),研究骨肉瘤的细胞化学特征与组织形态学之间的关系以及DNA含量的临床意义。组织切片的MSP存在确定切片细胞核DNA含量的方法学误差。通过分析184个正常间充质细胞群体,推导出二倍体(正常DNA含量)的上限。将此上限应用于42个肉瘤,其中6个为二倍体,36个为超二倍体。通过压片标本的MSP和FCM对相同病变进行比较分析,发现倍性分类(二倍体与超二倍体)完全一致。对骨肿瘤的回顾性MSP分析常常因先前的酸脱矿而受阻,酸脱矿会破坏DNA。发现乙二胺四乙酸(EDTA)作为替代方法会略微降低骨肉瘤的福尔根DNA染色性,但不影响肿瘤倍性的测定。因此,EDTA为需要脱矿的骨肿瘤保留DNA染色性提供了一种方法。对不同组织学区域的MSP分析以及对活检和手术标本的比较FCM分析表明,尽管形态学存在异质性,但单个骨肉瘤在细胞化学上是均匀的。因此,可依赖单个肿瘤样本进行DNA分析以代表整个肿瘤。在连续83例接受手术和辅助干扰素治疗的骨肉瘤患者系列中,7年生存率为0.44。MSP DNA分析未提供显著的预后信息。多变量分析确定了与肿瘤相关死亡的3个危险因素,即男性、肿瘤近端位置和组织学IV级。在一个预后模型中,具有0、1、2或3个危险因素的患者的7年生存率分别为0.80、0.59、0.42和0.13。因此,有可能识别出具有不同预后的高级别骨肉瘤患者亚组。在一项对166例原发性骨肿瘤的研究中,研究了DNA分析在鉴别诊断中的适用性。该系列包括高级别骨肉瘤、骨旁骨肉瘤和良性骨肿瘤,这些肿瘤在组织学上可能与骨肉瘤混淆。在166个肿瘤中,149个(90%)在组织学上无争议,而17个(10%)存在诊断困难。在诊断无争议的组中,所有良性肿瘤和骨旁骨肉瘤均为二倍体,而102个骨肉瘤中有97个为超二倍体。因此,超二倍体似乎是高级别骨肉瘤的一个特征性特征。(摘要截断于400字)

相似文献

1
DNA cytometry of osteosarcoma.骨肉瘤的DNA细胞计量术
Acta Orthop Scand Suppl. 1988;228:1-39. doi: 10.3109/17453678809154175.
2
DNA analysis in the differential diagnosis of osteosarcoma.DNA分析在骨肉瘤鉴别诊断中的应用
Cancer. 1988 Apr 1;61(7):1430-6. doi: 10.1002/1097-0142(19880401)61:7<1430::aid-cncr2820610725>3.0.co;2-m.
3
DNA analysis in the differential diagnosis of osteosarcoma.DNA分析在骨肉瘤鉴别诊断中的应用
Cancer. 1988 Jun 15;61(12):2532-40. doi: 10.1002/1097-0142(19880615)61:12<2532::aid-cncr2820611224>3.0.co;2-h.
4
7
Cellular DNA content in human osteosarcoma: aspects on diagnosis and prognosis.人类骨肉瘤中的细胞DNA含量:诊断与预后方面
Cancer. 1982 Dec 1;50(11):2476-81. doi: 10.1002/1097-0142(19821201)50:11<2476::aid-cncr2820501136>3.0.co;2-n.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验